Preclinical CRO Market Global Scenario, Market Size, Outlook, Trend, and Forecast, 2019 – 2028

TABLE OF CONTENTS

Chapter 1        Prefix

1.1    Market Scope

1.2    Report Description

1.3    Research Methodology

1.3.1      Primary Research

1.3.2      Secondary Research

1.3.3      In-house Data Modeling

Chapter 2        Executive Summary

2.1   Global Preclinical CRO Market Year-on-Year Growth, 2020 - 2028 (%)

Chapter 3        Market Outline

3.1    Market Inclination, Trend, Outlook and Viewpoint

3.2    Market Share Analysis: Company’s Competitive Scenario

3.3    Value Chain Analysis

3.4    Porter’s Five Forces Analysis

3.5    Market Dynamics

3.5.1      Drivers

3.5.1.1      Impact Analysis

3.5.2      Restraints

3.5.2.1      Impact Analysis

3.5.3      Opportunities

Chapter 4        Global Preclinical CRO Market by Service: Market Size and Forecast, 2019 – 2028

4.1    Overview

4.2  Bioanalysis and Drug Metabolism Pharmacokinetics (DMPK) Studies

4.2.1    Current Trend and Analysis

4.2.2    Market Size and Forecast, 2019 - 2028 ($ Billion)

4.2.3    Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.3  Toxicology Testing

4.3.1    Current Trend and Analysis

4.3.2    Market Size and Forecast, 2019 - 2028 ($ Billion)

4.3.3    Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.4  Others

4.4.1    Current Trend and Analysis

4.4.2    Market Size and Forecast, 2019 - 2028 ($ Billion)

4.4.3    Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

Chapter 5        Global Preclinical CRO Market: by End User: Market Size and Forecast, 2019 – 2028

5.1  Overview

5.2  Biopharmaceutical Companies

5.2.1    Current Trend and Analysis

5.2.2    Market Size and Forecast, 2019 - 2028 ($ Billion)

5.2.3    Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

5.3  Government and Academic Institutes

5.3.1    Current Trend and Analysis

5.3.2    Market Size and Forecast, 2019 - 2028 ($ Billion)

5.3.3    Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

5.4  Medical Device

5.4.1    Current Trend and Analysis

5.4.2    Market Size and Forecast, 2019 - 2028 ($ Billion)

5.4.3    Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

Chapter 6        Global Preclinical CRO Market by Geography: Market Size and Forecast, 2019 – 2028

6.1  Overview

6.1.1    Global Preclinical CRO Market Year-on-Year Growth, by region 2020 – 2028 (%)

6.2  North America

6.2.1    Current Trend and Analysis

6.2.2    Market Size and Forecast, 2019 - 2028 ($ Billion)

6.2.3    U.S.

6.2.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.2.3.2        By Service

6.2.3.3        By End User

6.2.4    Canada

6.2.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.2.4.2        By Service

6.2.4.3        By End User

6.2.5    Mexico

6.2.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.2.5.2        By Service

6.2.5.3        By End User

6.2.6      Rest of North America

6.2.6.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.2.6.2        By Service

6.2.6.3        By End User

6.3    Europe

6.3.1    Current Trend and Analysis

6.3.2    Market Size and Forecast, 2019 - 2028 ($ Billion)

6.3.3    UK

6.3.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.3.3.2        By Service

6.3.3.3        By End User

6.3.4    Russia

6.3.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.3.4.2        By Service

6.3.4.3        By End User

6.3.5    France

6.3.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.3.5.2        By Service

6.3.5.3        By End User

6.3.6    Italy

6.3.6.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.3.6.2        By Service

6.3.6.3        By End User

6.3.7    Germany

6.3.7.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.3.7.2        By Service

6.3.7.3        By End User

6.3.8    Rest of Europe

6.3.8.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.3.8.2        By Service

6.3.8.3        By End User

6.4    Asia-Pacific

6.4.1    Current Trend and Analysis

6.4.2    Market Size and Forecast, 2019 - 2028 ($ Billion)

6.4.3    China

6.4.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.4.3.2        By Service

6.4.3.3        By End User

6.4.4    India

6.4.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.4.4.2        By Service

6.4.4.3        By End User

6.4.5    Japan

6.4.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.4.5.2        By Service

6.4.5.3        By End User

6.4.6    Rest of Asia-Pacific

6.4.6.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.4.6.2        By Service

6.4.6.3        By End User

6.5    RoW

6.5.1    Current Trend and Analysis

6.5.2    Market Size and Forecast

6.5.3    South America

6.5.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.5.3.2        By Service

6.5.3.3        By End User

6.5.4    Middle East

6.5.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.5.4.2        By Service

6.5.4.3        By End User

6.5.5    Africa

6.5.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.5.5.2        By Service

6.5.5.3        By End User

Chapter 7        Company Profiles

7.1  Koninklijke Philips N.V.

7.1.1      Company Overview

7.1.2      Product Portfolio

7.1.3      Business Strategies

7.1.4      Financials

7.1.5      Recent Developments

7.2  Envigo Corporation

7.2.1      Company Overview

7.2.2      Product Portfolio

7.2.3      Business Strategies

7.2.4      Financials

7.2.5      Recent Developments

7.3  MPI Research

7.3.1      Company Overview

7.3.2      Product Portfolio

7.3.3      Business Strategies

7.3.4      Financials

7.3.5      Recent Developments

7.4  Eurofins Scientific

7.4.1      Company Overview

7.4.2      Product Portfolio

7.4.3      Business Strategies

7.4.4      Financials

7.4.5      Recent Developments

7.5  IQVIA

7.5.1      Company Overview

7.5.2      Product Portfolio

7.5.3      Business Strategies

7.5.4      Financials

7.5.5      Recent Developments

7.6  PAREXEL International Corporation

7.6.1      Company Overview

7.6.2      Product Portfolio

7.6.3      Business Strategies

7.6.4      Financials

7.6.5      Recent Developments

7.7  Charles River

7.7.1      Company Overview

7.7.2      Product Portfolio

7.7.3      Business Strategies

7.7.4      Financials

7.7.5      Recent Developments

7.8  ICON PLC

7.8.1      Company Overview

7.8.2      Product Portfolio

7.8.3      Business Strategies

7.8.4      Financials

7.8.5      Recent Developments

7.9  PRA Health Sciences

7.9.1      Company Overview

7.9.2      Product Portfolio

7.9.3      Business Strategies

7.9.4      Financials

7.9.5      Recent Developments

7.10       Medpace Inc

7.10.1   Company Overview

7.10.2   Product Portfolio

7.10.3   Business Strategies

7.10.4   Financials

7.10.5   Recent Developments

7.11       Laboratory Corporation of America Inc.

7.11.1   Company Overview

7.11.2   Product Portfolio

7.11.3   Business Strategies

7.11.4   Financials

7.11.5   Recent Developments

7.12       Pharmaceutical Product Development

7.12.1   Company Overview

7.12.2   Product Portfolio

7.12.3   Business Strategies

7.12.4   Financials

7.12.5   Recent Developments

7.13       LLC

7.13.1   Company Overview

7.13.2   Product Portfolio

7.13.3   Business Strategies

7.13.4   Financials

7.13.5   Recent Developments

7.14       WuXi AppTec

7.14.1   Company Overview

7.14.2   Product Portfolio

7.14.3   Business Strategies

7.14.4   Financials

7.14.5   Recent Developments

7.15       MD Biosciences

7.15.1   Company Overview

7.15.2   Product Portfolio

7.15.3   Business Strategies

7.15.4   Financials

7.15.5   Recent Developments